Andrew Whitman Goodyear

This inventor holds 10 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Second Genome, Inc., Genevive, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Whitman Goodyear. Retrieved from https://idiyas.com/inventor/andrew-whitman-goodyear

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

South San Francisco, CA (US) (2021)
Brisbane, CA (US) (2022)
Pacifica, CA (US) (2019 - 2023)

Company Filing History:

Years Active: 2019-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661383 - PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS (2026-06-23),

2. 12371456 - Proteins for the treatment of epithelial barrier function disorders (2025-07-29),

3. 12186364 - Proteins for the treatment of epithelial barrier function disorders (2025-01-07),

4. 12168677 - Proteins for the treatment of epithelial barrier function disorders (2024-12-17),

5. 11666627 - Proteins for the treatment of epithelial barrier function disorders (2023-06-06),

6. 11505583 - Proteins for the treatment of epithelial barrier function disorders (2022-11-22),

7. 11273198 - Proteins for the treatment of epithelial barrier function disorders (2022-03-15),

8. 11207376 - Proteins for the treatment of epithelial barrier function disorders (2021-12-28),

9. 11174293 - Proteins for the treatment of epithelial barrier function disorders (2021-11-16),

10. 10251933 - Proteins for the treatment of epithelial barrier function disorders (2019-04-09),

Title: The Innovations of Andrew Whitman Goodyear

Introduction

Andrew Whitman Goodyear is a notable inventor based in Pacifica, CA (US). He has made significant contributions to the field of therapeutic proteins, holding a total of six patents. His work focuses on addressing critical health issues related to gastrointestinal diseases.

Latest Patents

Goodyear's latest patents include innovative therapeutic proteins aimed at treating epithelial barrier function disorders. These proteins and their pharmaceutical compositions are designed to combat various human diseases, particularly gastrointestinal inflammatory diseases. They are especially useful for conditions associated with decreased epithelial cell barrier function or integrity. Notably, his work addresses human inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.

Career Highlights

Goodyear is currently employed at Second Genome, Inc., where he continues to advance his research and development efforts. His expertise in therapeutic proteins has positioned him as a key player in the biotechnology sector.

Collaborations

Some of his notable coworkers include Andrew Wonhee Han and Tarunmeet Gujral, with whom he collaborates on various projects within the company.

Conclusion

Andrew Whitman Goodyear's contributions to the field of therapeutic proteins are significant and impactful. His innovative work continues to pave the way for advancements in treating gastrointestinal diseases.

Profile summary based on public USPTO records.